BRIGHTON JONES LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIGHTON JONES LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$22,000
-64.5%
369,0110.0%0.00%
-75.0%
Q2 2022$62,000
-64.2%
369,0110.0%0.00%
-50.0%
Q1 2022$173,000
-17.6%
369,0110.0%0.01%
-20.0%
Q4 2021$210,000
-65.7%
369,0110.0%0.01%
-68.8%
Q3 2021$613,000
+115.1%
369,011
+116.5%
0.03%
+113.3%
Q2 2021$285,000
-54.3%
170,456
-53.8%
0.02%
-59.5%
Q1 2021$624,000
-1.6%
369,011
-7.5%
0.04%
-5.1%
Q4 2020$634,000
+89.8%
398,912
+14.3%
0.04%
+69.6%
Q3 2020$334,000
+163.0%
348,912
+74.8%
0.02%
+130.0%
Q2 2020$127,000
+53.0%
199,555
+0.3%
0.01%
+11.1%
Q1 2020$83,000
-8.8%
199,000
+27.6%
0.01%
-10.0%
Q4 2019$91,000
+82.0%
156,010
+55.1%
0.01%
+66.7%
Q3 2019$50,000
+28.2%
100,5550.0%0.01%
+20.0%
Q2 2019$39,000
-31.6%
100,5550.0%0.01%
-28.6%
Q1 2019$57,000
+42.5%
100,5550.0%0.01%
+16.7%
Q4 2018$40,000
-21.6%
100,5550.0%0.01%0.0%
Q3 2018$51,000
-72.9%
100,555
+17.5%
0.01%
-75.0%
Q2 2018$188,000
-35.4%
85,5550.0%0.02%
-40.0%
Q1 2018$291,000
+134.7%
85,555
+180.0%
0.04%
+166.7%
Q4 2017$124,000
+552.6%
30,5550.0%0.02%
+650.0%
Q3 2017$19,000
+18.8%
30,5550.0%0.00%0.0%
Q2 2017$16,00030,5550.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CVA Family Office, LLC 1,173,200$1,865,0001.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$1,387,0000.82%
Cypress Capital Management LLC (WY) 214,575$341,0000.30%
Western Wealth Management, LLC 982,350$1,562,0000.23%
SRS Capital Advisors, Inc. 615,659$979,0000.14%
Willis Investment Counsel 1,213,053$1,929,0000.13%
Harvest Investment Services, LLC 124,423$197,0000.10%
Transform Wealth, LLC 205,481$327,0000.07%
COURIER CAPITAL LLC 379,973$604,0000.07%
BRIGHTON JONES LLC 398,912$634,0000.04%
View complete list of AMPIO PHARMACEUTICALS INC shareholders